Home/Bimini Biotech/Maurits van den Nieuwboer, PhD
MV

Maurits van den Nieuwboer, PhD

COO

Bimini Biotech

Bimini Biotech Pipeline

DrugIndicationPhase
BM-011 / WASp modulator portfolioLeukemias, Lymphomas, Autoimmune diseases (e.g., arthritis, colitis)Preclinical